About Owens & Minor (NYSE:OMI)
Owens & Minor, Inc. is a healthcare services company that connects the world of medical products to the point of care. The Company provides supply chain assistance to the providers of healthcare services and the manufacturers of healthcare products, supplies and devices. The Company's segments include Domestic, International and Clinical & Procedural Solutions (CPS). The Domestic Segment offers a portfolio of products and services to healthcare providers and manufacturers in the United States. The Company also offers additional services to healthcare providers, including supplier management, analytics, inventory management, outsourced resource management, clinical supply management and business process consulting. The International segment includes its European distribution and logistics business. The CPS segment provides product-related solutions, helping manufacturers and healthcare providers source, assemble and deliver procedure kits to the point-of-care.
Industry, Sector and Symbol
Industry Medical & hospital equipment
Sub-IndustryHealth Care Distributors
SectorMedical
SymbolNYSE:OMI
CUSIP69073210
Phone804-723-7000
Debt
Debt-to-Equity Ratio0.89%
Current Ratio1.67%
Quick Ratio0.91%
Price-To-Earnings
Trailing P/E Ratio9.72
Forward P/E Ratio7.37
P/E Growth0.95
Sales & Book Value
Annual Sales$9.32 billion
Price / Sales0.10
Cash Flow$2.5058 per share
Price / Cash6.03
Book Value$16.58 per share
Price / Book0.91
Profitability
EPS (Most Recent Fiscal Year)$1.61
Net Income$72.79 million
Net Margins0.78%
Return on Equity9.63%
Return on Assets3.14%
Miscellaneous
Employees8,600
Outstanding Shares61,520,000
Owens & Minor (NYSE:OMI) Frequently Asked Questions
What is Owens & Minor's stock symbol?
Owens & Minor trades on the New York Stock Exchange (NYSE) under the ticker symbol "OMI."
How often does Owens & Minor pay dividends? What is the dividend yield for Owens & Minor?
Owens & Minor announced a quarterly dividend on Tuesday, January 30th. Stockholders of record on Thursday, March 15th will be paid a dividend of $0.26 per share on Friday, March 30th. This represents a $1.04 annualized dividend and a dividend yield of 6.88%. The ex-dividend date is Wednesday, March 14th. This is a boost from Owens & Minor's previous quarterly dividend of $0.26. View Owens & Minor's Dividend History.
How were Owens & Minor's earnings last quarter?
Owens & Minor (NYSE:OMI) issued its quarterly earnings results on Wednesday, February, 14th. The company reported $0.35 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.34 by $0.01. The company had revenue of $2.39 billion for the quarter, compared to analysts' expectations of $2.34 billion. Owens & Minor had a net margin of 0.78% and a return on equity of 9.63%. Owens & Minor's quarterly revenue was up .9% compared to the same quarter last year. During the same period last year, the company earned $0.52 earnings per share. View Owens & Minor's Earnings History.
When is Owens & Minor's next earnings date?
What guidance has Owens & Minor issued on next quarter's earnings?
Owens & Minor issued an update on its FY17 earnings guidance on Wednesday, January, 31st. The company provided earnings per share (EPS) guidance of $1.58-1.61 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.77. The company issued revenue guidance of $9.20-9.32 billion, compared to the consensus revenue estimate of $9.41 billion.
What price target have analysts set for OMI?
8 analysts have issued 12 month price objectives for Owens & Minor's shares. Their predictions range from $16.00 to $32.00. On average, they anticipate Owens & Minor's stock price to reach $23.0625 in the next twelve months. View Analyst Ratings for Owens & Minor.
Who are some of Owens & Minor's key competitors?
Some companies that are related to Owens & Minor include Arena Pharmaceuticals (ARNA), Rhön-Klinikum (RHK), Denali Therapeutics (DNLI), Aimmune Therapeutics (AIMT), Cambrex (CBM), Clinigen Group (CLIGF), Integer (ITGR), OPKO Health (OPK), Insmed (INSM), CONMED (CNMD), Phibro Animal Health (PAHC), MyoKardia (MYOK), Omnicell Technologies (OMCL), Acceleron Pharma (XLRN), Madrigal Pharmaceuticals (MDGL), NxStage (NXTM), Abaxis (ABAX) and Sangamo Therapeutics (SGMO).
Who are Owens & Minor's key executives?
Owens & Minor's management team includes the folowing people:
- P. Cody Phipps, Chairman of the Board, President, Chief Executive Officer (Age 55)
- Richard A. Meier, Chief Financial Officer, Executive Vice President, President - International (Age 57)
- Christopher M. Lowery, President - Global Products (Age 53)
- Erika T. Davis, Senior Vice President, Chief Administrative Officer (Age 53)
- Nicholas J. Pace Esq., Senior Vice President, General Counsel, Corporate Secretary (Age 46)
- Jay Romans, Senior Vice President - Human Resources (Age 66)
- Charles C. Colpo, Senior Vice President - Strategic Relationships (Age 59)
- Geoffrey T. Marlatt, Senior Vice President-Manufacturing Services (Age 48)
- Anne Marie Whittemore, Lead Independent Director (Age 70)
- Mark F. McGettrick, Director (Age 60)
Has Owens & Minor been receiving favorable news coverage?
Media coverage about OMI stock has been trending positive on Saturday, Accern Sentiment Analysis reports. The research firm rates the sentiment of news coverage by analyzing more than twenty million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Owens & Minor earned a news sentiment score of 0.42 on Accern's scale. They also assigned news coverage about the company an impact score of 46.63 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of Owens & Minor?
Shares of OMI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Owens & Minor's stock price today?
One share of OMI stock can currently be purchased for approximately $15.11.
How big of a company is Owens & Minor?
Owens & Minor has a market capitalization of $950.42 million and generates $9.32 billion in revenue each year. The company earns $72.79 million in net income (profit) each year or $1.61 on an earnings per share basis. Owens & Minor employs 8,600 workers across the globe.
How can I contact Owens & Minor?
Owens & Minor's mailing address is 9120 LOCKWOOD BOULEVARD, MECHANICSVILLE VA, 23116. The company can be reached via phone at 804-723-7000 or via email at [email protected]
MarketBeat Community Rating for Owens & Minor (OMI)
MarketBeat's community ratings are surveys of what our community members think about Owens & Minor and other stocks. Vote "Outperform" if you believe OMI will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMI will underperform the S&P 500 over the long term. You may vote once every thirty days.
Owens & Minor (NYSE:OMI) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
8 Wall Street analysts have issued ratings and price targets for Owens & Minor in the last 12 months. Their average twelve-month price target is $23.0625, suggesting that the stock has a possible upside of 52.63%. The high price target for OMI is $32.00 and the low price target for OMI is $16.00. There are currently 4 sell ratings, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus rating of "Hold."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
| Consensus Rating: | Hold | Hold | Hold | Hold |
| Consensus Rating Score: | 1.63 | 1.63 | 1.50 | 1.50 |
| Ratings Breakdown: | 4 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 4 Sell Rating(s)
3 Hold Rating(s)
1 Buy Rating(s)
0 Strong Buy Rating(s) | 3 Sell Rating(s)
3 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) | 2 Sell Rating(s)
2 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s) |
| Consensus Price Target: | $23.0625 | $23.0625 | $25.25 | $30.3750 |
| Price Target Upside: | 52.63% upside | 34.79% upside | 34.67% upside | 8.13% upside |
Owens & Minor (NYSE:OMI) Consensus Price Target History
Owens & Minor (NYSE:OMI) Analyst Ratings History
Show:
(Data available from 4/21/2016 forward)
Owens & Minor (NYSE:OMI) Dividend Information
Owens & Minor pays an annual dividend of $1.04 per share, with a dividend yield of 6.88%. OMI's most recent quarterly dividend payment was Friday, March 30. The company has grown its dividend for the last 19 consecutive years and is increasing its dividend by an average of 1.00% each year. Owens & Minor pays out 64.60% of its earnings out as a dividend.
| Most Recent Dividend: | 3/30/2018 |
| Annual Dividend: | $1.04 |
| Dividend Yield: | 6.88% |
| Dividend Growth: | 1.00% (3 Year Average) |
| Payout Ratio: | 64.60% (Trailing 12 Months of Earnings)
50.73% (Based on This Year's Estimates)
46.43% (Based on Next Year's Estimates)
|
| Track Record: | 19 Years of Consecutive Dividend Growth |
| Frequency: | Quarterly Dividend |
Owens & Minor (NYSE:OMI) Dividend History by Quarter
| Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
|---|
| 1/30/2018 | Quarterly | $0.26 | 6.69% | 3/14/2018 | 3/15/2018 | 3/30/2018 |
| 11/1/2017 | quarterly | $0.2575 | 5.52% | 12/14/2017 | 12/15/2017 | 12/29/2017 |
| 8/2/2017 | quarterly | $0.2575 | 3.4% | 9/14/2017 | 9/15/2017 | 9/29/2017 |
| 5/4/2017 | quarterly | $0.2575 | 3.14% | 6/13/2017 | 6/15/2017 | 6/30/2017 |
| 2/14/2017 | quarterly | $0.2575 | 2.95% | 3/13/2017 | 3/15/2017 | 3/31/2017 |
| 11/1/2016 | quarterly | $0.2250 | | 12/13/2016 | 12/15/2016 | 12/30/2016 |
| 8/2/2016 | quarterly | $0.2550 | | 9/13/2016 | 9/15/2016 | 9/30/2016 |
| 5/5/2016 | quarterly | $0.2550 | | 6/13/2016 | 6/15/2016 | 6/30/2016 |
| 2/8/2016 | quarterly | $0.2550 | | 3/11/2016 | 3/15/2016 | 3/31/2016 |
| 10/27/2015 | quarterly | $0.2525 | | 12/11/2015 | 12/15/2015 | 12/31/2015 |
| 7/27/2015 | quarterly | $0.2525 | | 9/11/2015 | 9/15/2015 | 9/30/2015 |
| 4/29/2015 | quarterly | $0.2525 | 3% | 6/11/2015 | 6/15/2015 | 6/30/2015 |
| 2/17/2015 | quarterly | $0.2525 | 2.9% | 3/12/2015 | 3/16/2015 | 3/31/2015 |
| 10/27/2014 | quarterly | $0.25 | 3.03% | 12/11/2014 | 12/15/2014 | 12/31/2014 |
| 7/28/2014 | quarterly | $0.25 | 2.97% | 9/11/2014 | 9/15/2014 | 9/30/2014 |
| 5/1/2014 | quarterly | $0.25 | 3.01% | 6/12/2014 | 6/16/2014 | 6/30/2014 |
| 2/10/2014 | quarterly | $0.25 | 2.83% | 3/13/2014 | 3/17/2014 | 3/31/2014 |
| 11/4/2013 | quarterly | $0.24 | 2.6% | 12/12/2013 | 12/16/2013 | 12/31/2013 |
| 7/29/2013 | quarterly | $0.24 | 2.75% | 9/12/2013 | 9/16/2013 | 9/30/2013 |
| 4/25/2013 | quarterly | $0.24 | 2.97% | 6/12/2013 | 6/14/2013 | 6/28/2013 |
| 2/11/2013 | quarterly | $0.24 | 3.13% | 3/13/2013 | 3/15/2013 | 3/29/2013 |
(Data available from 1/1/2013 forward)
Owens & Minor (NYSE OMI) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 1.68%
Institutional Ownership Percentage: 96.96%
Owens & Minor (NYSE OMI) Insider Trading History
| Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
|---|
| 5/24/2017 | Rony Camil Kordahi | EVP | Sell | 2,231 | $32.07 | $71,548.17 | 27,555 |  |
| 5/23/2017 | Erika T Davis | SVP | Sell | 9,317 | $32.26 | $300,566.42 | 63,979 | |
| 5/9/2017 | Michael Wayne Lowry | Insider | Sell | 1,300 | $32.19 | $41,847.00 | 10,498 | |
| 4/17/2017 | Craig R Smith | Director | Sell | 20,000 | $33.79 | $675,800.00 | 25,753 | |
| 2/28/2017 | Charles C Colpo | SVP | Sell | 8,802 | $36.04 | $317,224.08 | 38,705 | |
| 2/21/2017 | Michael Wayne Lowry | Insider | Sell | 400 | $35.00 | $14,000.00 | 4,730 | |
| 1/23/2017 | Craig R Smith | Director | Sell | 20,000 | $35.81 | $716,200.00 | 49,732 | |
| 1/9/2017 | Craig R Smith | Director | Sell | 25,000 | $36.22 | $905,500.00 | 69,732 | |
| 11/28/2016 | Charles C Colpo | SVP | Sell | 7,500 | $34.33 | $257,475.00 | 38,829 | |
| 8/31/2016 | Erika T Davis | SVP | Sell | 2,900 | $34.31 | $99,499.00 | 61,867 | |
| 8/5/2016 | Craig R Smith | Director | Sell | 7,500 | $35.42 | $265,650.00 | 104,482 | |
| 5/9/2016 | Craig R Smith | Director | Sell | 5,000 | $35.93 | $179,650.00 | 116,982 | |
| 5/9/2016 | Michael Wayne Lowry | Insider | Sell | 1,181 | $35.88 | $42,374.28 | 5,219 | |
| 3/31/2016 | Erika T Davis | SVP | Sell | 6,492 | $39.54 | $256,693.68 | 64,891 | |
| 2/26/2016 | Charles C Colpo | SVP | Sell | 7,438 | $39.51 | $293,875.38 | 46,329 | |
| 2/23/2016 | Richard W Mears | SVP | Sell | 6,000 | $39.11 | $234,660.00 | 38,078 | |
| 2/22/2016 | James E Rogers | Director | Sell | 1,800 | $39.83 | $71,694.00 | 55,552 | |
| 2/17/2016 | Erika T Davis | SVP | Sell | 5,301 | $38.70 | $205,148.70 | 71,383 | |
| 2/10/2016 | Craig R Smith | Director | Sell | 11,026 | $37.87 | $417,554.62 | 118,335 | |
| 2/10/2016 | Michael Wayne Lowry | insider | Sell | 184 | $37.84 | $6,962.56 | 4,152 | |
| 11/16/2015 | Craig R Smith | Director | Sell | 15,000 | $37.51 | $562,650.00 | 121,029 | |
| 11/9/2015 | Grace R. Denttartog | SVP | Sell | 2,751 | $36.37 | $100,053.87 | 51,983 | |
| 8/26/2015 | David S Simmons | Director | Buy | 2,200 | $32.75 | $72,050.00 | 9,422 | |
| 8/14/2015 | Charles C Colpo | SVP | Sell | 10,763 | $34.82 | $374,767.66 | | |
| 4/29/2015 | Michael Wayne Lowry | Insider | Sell | 1,110 | $34.50 | $38,295.00 | | |
| 2/20/2015 | Stuart Essig | Director | Buy | 14,489 | $34.51 | $500,015.39 | | |
| 2/19/2015 | Craig R Smith | Chairman | Sell | 50,000 | $34.48 | $1,724,000.00 | | |
| 11/25/2014 | Erika T Davis | SVP | Sell | 11,755 | $33.94 | $398,964.70 | | |
| 10/31/2014 | Robert C Sledd | Director | Sell | 6,088 | $33.36 | $203,095.68 | | |
| 10/1/2014 | Craig R Smith | Chairman | Sell | 33,000 | $32.51 | $1,072,830.00 | | |
| 9/17/2014 | Craig R Smith | Chairman | Sell | 33,000 | $34.38 | $1,134,540.00 | | |
| 9/3/2014 | Craig R Smith | Chairman | Sell | 33,000 | $34.18 | $1,127,940.00 | | |
| 5/8/2014 | Robert Sledd | Director | Sell | 3,750 | $32.75 | $122,812.50 | 20,110 | |
| 5/7/2014 | Richard Meier | CFO | Buy | 2,500 | $32.50 | $81,250.00 | 40,566 | |
| 5/6/2014 | Sumeren Mark Van | SVP | Sell | 1,800 | $32.54 | $58,572.00 | 23,598 | |
| 2/28/2014 | Richard Meier | CFO | Buy | 2,500 | $34.85 | $87,125.00 | 38,066 | |
| 2/26/2014 | Grace Denttartog | SVP | Sell | 7,750 | $34.76 | $269,390.00 | 54,026 | |
| 2/13/2014 | James Rogers | Director | Sell | 7,500 | $35.33 | $264,975.00 | 50,063 | |
| 2/12/2014 | Craig Smith | CEO | Sell | 43,000 | $35.42 | $1,523,060.00 | 305,712 | |
| 11/13/2013 | Anne Whittemore | Director | Sell | 22,500 | $37.46 | $842,850.00 | 32,968 | |
| 8/14/2013 | Sumeren Mark Van | SVP | Sell | 2,500 | $36.22 | $90,550.00 | 23,112 | |
| 7/31/2013 | Richard W Mears | SVP | Sell | 3,000 | $35.38 | $106,140.00 | | |
| 5/31/2013 | Craig R Smith | CEO | Sell | 37,500 | $34.49 | $1,293,375.00 | | |
| 5/30/2013 | Richard E Fogg | Director | Sell | 2,322 | $35.00 | $81,270.00 | | |
| 5/20/2013 | Anne M Whittemore | Director | Sell | 7,500 | $34.30 | $257,250.00 | | |
| 5/15/2013 | Richard E Fogg | Director | Sell | 15,000 | $33.90 | $508,500.00 | | |
| 5/9/2013 | Grace R Denttartog | SVP | Sell | 8,000 | $33.32 | $266,560.00 | | |
| 2/26/2013 | G Gilmer Minor III | Director | Sell | 14,236 | $30.44 | $433,343.84 | | |
| 2/15/2013 | Erika T Davis | VP | Sell | 7,625 | $31.60 | $240,950.00 | | |
| 2/15/2013 | Sumeren Mark A Van | SVP | Sell | 1,700 | $31.49 | $53,533.00 | | |
| 2/14/2013 | Charles C Colpo | SVP | Sell | 15,000 | $31.32 | $469,800.00 | | |
| 2/14/2013 | Eddie N Moore Jr | Director | Sell | 7,500 | $31.29 | $234,675.00 | | |
(Data available from 1/1/2013 forward)
Owens & Minor (NYSE OMI) News Headlines
| Source: |
|
| Date | Headline |
|---|
 | Owens & Minor (OMI) Rating Lowered to Sell at BidaskClub
www.americanbankingnews.com - April 19 at 9:53 AM |
 | Acquisition Cycle Creates Value Opportunity With Molson Coors
seekingalpha.com - April 19 at 8:58 AM |
| Owens & Minor (OMI) Lowered to "Sell" at Zacks Investment Research
www.americanbankingnews.com - April 18 at 10:04 AM |
 | This Morning's Technical Outlook on Services Stocks -- WageWorks, Henry Schein, Owens & Minor, and Patterson
www.bizjournals.com - April 18 at 9:01 AM |
 | Drug suppliers' shares rise as looming Amazon threat appears to ease
finance.yahoo.com - April 16 at 4:46 PM |
| Owens & Minor (OMI) Given "Sell" Rating at UBS
www.americanbankingnews.com - April 13 at 1:03 PM |
| Owens & Minor (OMI) Rating Increased to Buy at Zacks Investment Research
www.americanbankingnews.com - April 13 at 12:59 PM |
| Owens & Minor's (OMI) Sell Rating Reiterated at UBS
www.americanbankingnews.com - April 12 at 3:58 PM |
| Owens & Minor (OMI) Given Consensus Recommendation of "Hold" by Brokerages
www.americanbankingnews.com - April 11 at 5:43 PM |
 | Owens & Minor, Inc.
www.streetinsider.com - April 11 at 4:53 PM |
| Another Healthcare Company That Bites The Dust
seekingalpha.com - April 11 at 9:33 AM |
| $2.39 Billion in Sales Expected for Owens & Minor (OMI) This Quarter
www.americanbankingnews.com - April 8 at 2:28 AM |
| Form 4 OWENS & MINOR INC/VA/ For: Apr 04 Filed by: Kordahi Rony Camil
www.streetinsider.com - April 7 at 3:57 PM |
| Owens & Minor (OMI) Expected to Announce Earnings of $0.47 Per Share
www.americanbankingnews.com - April 6 at 5:13 PM |
| Owens & Minor (OMI) Upgraded to "Hold" at Zacks Investment Research
www.americanbankingnews.com - April 4 at 11:15 AM |
| Owens & Minor (OMI) Downgraded by ValuEngine to "Sell"
www.americanbankingnews.com - April 3 at 10:32 AM |
| Owens & Minor (OMI) Upgraded to Hold by Zacks Investment Research
www.americanbankingnews.com - March 31 at 9:22 PM |
 | BRIEF-Owens & Minor CEO P. Cody Phipps' Total Pay For 2017 Was $6.7 Mln Vs $6.3 Mln In 2016 - SEC Filing
www.reuters.com - March 27 at 9:20 AM |
| Free Post Earnings Research Report: Owens & Minor Reported Better Than Expected Results
finance.yahoo.com - March 26 at 9:20 AM |
| Owens & Minor (OMI) Stock Rating Lowered by Zacks Investment Research
www.americanbankingnews.com - March 25 at 11:41 AM |
| Bank of America Initiates Coverage on Owens & Minor (OMI)
www.americanbankingnews.com - March 24 at 9:30 PM |
| Owens & Minor: The Numbers Make A Bull Case, The Business ... - Seeking Alpha
seekingalpha.com - March 23 at 4:57 PM |
| Owens & Minor (OMI) Receives Average Rating of "Hold" from Analysts
www.americanbankingnews.com - March 17 at 5:30 PM |
| Take-Two Interactive Software, SVB Financial and Nektar Pharmaceuticals Set to Join S&P 500; Others to Join S&P MidCap 400 and S&P SmallCap 600
finance.yahoo.com - March 9 at 5:59 PM |
| Owens & Minor, Inc. (OMI) Increases Dividend to $0.26 Per Share
www.americanbankingnews.com - March 9 at 12:06 PM |
| March Undervalued Utilities Stock Opportunities
finance.yahoo.com - March 9 at 9:23 AM |
| Barclays Initiates Coverage on Owens & Minor (OMI)
www.americanbankingnews.com - March 9 at 12:10 AM |
| OppenheimerFunds Inc. Has $16.13 Million Stake in Owens & Minor, Inc. (OMI)
www.americanbankingnews.com - March 6 at 11:36 AM |
| Owens & Minor, Inc. (OMI) Expected to Post Quarterly Sales of $2.39 Billion
www.americanbankingnews.com - March 5 at 9:28 AM |
| Owens & Minor, Inc. (OMI) Expected to Announce Earnings of $0.47 Per Share
www.americanbankingnews.com - March 3 at 4:20 PM |
| Owens & Minor, Inc. (OMI) Holdings Increased by Suntrust Banks Inc.
www.americanbankingnews.com - March 2 at 8:24 PM |
| Owens & Minor Names Dominion Energy Executive, Mark McGettrick, to its Board of Directors
finance.yahoo.com - February 28 at 5:24 PM |
| Owens & Minor: What The Heck Happened?
seekingalpha.com - February 27 at 5:23 PM |
| Systematic Financial Management LP Purchases 29,570 Shares of Owens & Minor, Inc. (OMI)
www.americanbankingnews.com - February 27 at 11:28 AM |
| Owens & Minor, Inc. (OMI) Shares Bought by Brandes Investment Partners LP
www.americanbankingnews.com - February 27 at 5:04 AM |
| How Amazon Is Disrupting the Healthcare Industry
finance.yahoo.com - February 26 at 5:16 PM |
| Owens & Minor, Inc. (OMI) Stake Lifted by Adirondack Research & Management Inc.
www.americanbankingnews.com - February 26 at 5:10 AM |
| Aperio Group LLC Acquires 9,814 Shares of Owens & Minor, Inc. (OMI)
www.americanbankingnews.com - February 25 at 4:14 AM |
| Owens & Minor, Inc. (OMI) Position Boosted by Royce & Associates LP
www.americanbankingnews.com - February 24 at 10:24 AM |
| Owens & Minor, Inc. (OMI) Given Consensus Recommendation of "Sell" by Analysts
www.americanbankingnews.com - February 20 at 5:32 PM |
| Leerink Swann Analysts Cut Earnings Estimates for Owens & Minor, Inc. (OMI)
www.americanbankingnews.com - February 19 at 2:02 AM |
| Zacks: Analysts Anticipate Owens & Minor, Inc. (OMI) Will Post Quarterly Sales of $2.36 Billion
www.americanbankingnews.com - February 16 at 4:04 AM |
| Why Drug Suppliers Are Getting Hit As AmerisourceBergen Soars On Walgreens Report
finance.yahoo.com - February 15 at 4:54 PM |
| Owens & Minor (OMI) PT Lowered to $20.00 at JPMorgan Chase & Co.
www.americanbankingnews.com - February 15 at 12:00 PM |
| Equities Analysts Issue Forecasts for Owens & Minor, Inc.'s Q1 2018 Earnings (OMI)
www.americanbankingnews.com - February 15 at 8:30 AM |
| Zacks: Brokerages Anticipate Owens & Minor, Inc. (OMI) Will Announce Earnings of $0.38 Per Share
www.americanbankingnews.com - February 14 at 9:08 PM |
| Owens & Minor's (OMI) CEO Paul Phipps on Q4 2017 Results - Earnings Call Transcript
seekingalpha.com - February 14 at 5:04 PM |
| Owens & Minor tops Street 4Q forecasts
finance.yahoo.com - February 14 at 5:04 PM |
| Owens & Minor (OMI) Announces Earnings Results
www.americanbankingnews.com - February 14 at 11:12 AM |
| [$$] Amazon’s Latest Ambition: To Be a Major Hospital Supplier
finance.yahoo.com - February 14 at 9:27 AM |
Owens & Minor (NYSE:OMI) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Owens & Minor (NYSE:OMI) Income Statement, Balance Sheet and Cash Flow Statement
Owens & Minor (NYSE OMI) Stock Chart for Saturday, April, 21, 2018
Loading chart…
